Mammograms are safe for the vast majority of women, and the benefits of early cancer detection far outweigh the small risks involved. The radiation dose from a standard digital mammogram is roughly equivalent to about seven weeks of natural background radiation, which is the amount you absorb just living your daily life. That said, “safe” covers more than just radiation. There are real trade-offs worth understanding, from false positives to the physical discomfort of compression.
How Much Radiation You Actually Get
A standard two-view digital mammogram delivers about 3.7 to 3.9 milligray (mGy) of radiation to the breast tissue. For context, the average person in the U.S. absorbs about 3.1 millisieverts per year from natural background sources like radon, cosmic rays, and the soil. A single mammogram adds a tiny fraction on top of that annual exposure.
The more important question is what that radiation means over a lifetime of screening. A modeling study published in the Annals of Internal Medicine projected that annual mammograms from ages 40 to 74 would cause roughly 125 radiation-induced breast cancers per 100,000 women screened, leading to about 16 deaths. In the same group, early detection from screening would avert approximately 968 breast cancer deaths. That’s a ratio of roughly 60 lives saved for every one life lost to radiation-induced cancer. The math strongly favors screening.
3D Mammography and Radiation
Three-dimensional mammography (tomosynthesis) delivers about 38% more radiation per view than a standard 2D digital mammogram. In absolute terms, that’s roughly 1.9 mGy per view compared to 1.4 mGy. This is a modest increase, and newer machines can generate a synthetic 2D image from the 3D scan, eliminating the need to take both types separately. Most radiologists consider the improved accuracy of 3D imaging well worth the slightly higher dose.
The Compression Factor
The breast compression during a mammogram applies up to about 45 pounds of force, and it can range from mildly uncomfortable to genuinely painful. Up to three-quarters of women report some degree of pain during the procedure. In rare cases, compression can cause visible bruising on the skin.
For most women with healthy breast tissue, compression does not cause lasting damage. The situation is different for women with breast implants, cysts, or certain other conditions. The FDA has received reports of implant ruptures suspected to have occurred during mammographic compression, affecting both silicone and saline implants. Other reported problems include implants being crushed by compression, significant pain, and inability to complete the mammogram due to capsular contracture. If you have breast implants, your imaging center should use a specialized displacement technique that gently pushes the implant back so the breast tissue can be imaged with less pressure on the implant itself. Always tell your technologist about implants before the exam begins.
False Positives Are Common
About 10% of mammograms result in a callback for additional imaging. Of those callbacks, only about 7% ultimately reveal cancer. The rest are false alarms caused by dense tissue, overlapping structures, cysts, or other benign findings. Over a decade of annual screening, more than half of women will experience at least one false positive result, and many will undergo a biopsy that turns out to be benign.
False positives carry real costs: anxiety, additional imaging appointments, potential biopsies, and for some women, avoidance of future screening altogether. A National Cancer Institute analysis found that women who experience a false positive are less likely to return for their next mammogram, which can be counterproductive since consistent screening is what drives the mortality benefit.
The Overdiagnosis Problem
Overdiagnosis is a subtler issue than false positives. It refers to cancers that are real but so slow-growing they would never have caused symptoms or threatened the person’s life. Estimates of the overdiagnosis rate in breast cancer screening range from 10% to 40%, depending on the study and how overdiagnosis is defined. These cases often lead to surgery, radiation therapy, or other treatments that carry their own risks, all for a cancer that didn’t need treating.
The challenge is that doctors currently cannot reliably distinguish an indolent cancer from an aggressive one at the time of diagnosis. Research is moving toward identifying which early-stage findings can be safely monitored with imaging rather than immediately biopsied, but for now, most detected abnormalities are treated. This is one of the genuine downsides of screening, and it’s worth weighing alongside the clear mortality benefit.
Screening During Pregnancy and Breastfeeding
Mammograms are considered safe during pregnancy. The scatter radiation reaching the fetus is negligible. However, pregnancy causes the breasts to enlarge and become denser, which makes mammograms harder to read. Ultrasound is generally more sensitive in this situation and is often recommended as the first-line imaging tool, particularly for women under 40. For pregnant women 40 and older, mammography or 3D tomosynthesis remains appropriate as an initial assessment.
During breastfeeding, mammograms can still be performed, though increased breast density from lactation may reduce image quality. Biopsies during pregnancy or lactation carry a slightly higher risk of bleeding and a small chance of developing a milk fistula (an abnormal connection between a milk duct and the skin). Contrast-enhanced MRI is not recommended during pregnancy because the contrast agent crosses the placenta.
Current Screening Recommendations
The U.S. Preventive Services Task Force updated its guidelines to recommend that all women begin screening mammograms at age 40, continuing every two years through age 74. This was a notable shift: previously, the task force suggested women in their 40s make an individual decision about when to start. The updated recommendation reflects growing evidence that earlier screening catches more cancers at treatable stages, particularly in Black women, who are more likely to develop aggressive breast cancers at younger ages.
Women with a family history of breast cancer, known genetic mutations, or a history of chest radiation may need to start screening earlier or use additional imaging like MRI. Your risk profile determines whether the standard schedule is sufficient or whether a more intensive approach makes sense.
Weighing the Trade-Offs
The clearest evidence in favor of mammograms comes from a study of more than 549,000 women aged 40 to 69: those who participated in screening had a 41% reduction in their risk of dying from breast cancer within 10 years. Even after adjusting for biases that could inflate that number, the reduction held at 34%. That translates to thousands of lives saved every year across the population.
Against that benefit, the risks are real but comparatively small. Radiation exposure is minimal. Compression discomfort is temporary for most women. False positives are common but usually resolved with additional imaging. Overdiagnosis remains the most significant concern, potentially leading to unnecessary treatment in a meaningful minority of cases. For most women between 40 and 74, the survival benefit of regular screening substantially outweighs these risks.